This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Infectious Diseases, Other  • Endocrine Diseases  • Diabetes Mellitus  • Hematology/ Hematologic Malignancies  • Hematology, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2009;301(15):1527.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

After improper use of insulin pens at two hospitals put more than 2000 patients at risk of contracting a blood-borne disease, the US Food and Drug Administration (FDA) is warning clinicians and patients about the risks of sharing insulin pens and cartridges.

The agency issued the warning in March after it became aware that medical personnel at two Army hospitals had used multidose insulin pens intended for use by a single patient on multiple patients. According to the FDA, although the staff at the two hospitals reportedly changed the disposable needles used in the devices between patients, the pen itself or the insulin cartridge might have become contaminated, putting subsequent patients at risk.

In late January, officials at William Beaumont Army Medical Center in El Paso, Tex, became aware that between August 2007, when multidose insulin pens were first used at the hospital, and January 2009, staff . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?